Laurie Batchelder
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Laurie Batchelder has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Eirini-Christina Saloniki
Global Business School for Health University College London UCL East (Marshgate) 7 Sidings Street E20 2AE Stratford London United Kingdom
4 shared publications - Juliette Malley
Affiliation Care Policy and Evaluation Centre, The London School of Economics and Political Science, London, United Kingdom
4 shared publications - Birgit Trukeschitz
Research Institute for Economics of Aging, WU Vienna University of Economics and Business, Welthandelsplatz 1, Building D5, Vienna, 1020, Austria, 43 1 31336 5398
3 shared publications Hui Lu
RAND Europe, Cambridge, UK
3 shared publicationsIsmo Linnosmaa
Centre for Health and Social Economics, National Institute for Health and Welfare (THL), Helsinki, Finland; Department of Health and Social Management, University of Eastern Finland, Kuopio, Finland
3 shared publications- Diane Fox
Personal Social Services Research Unit, University of Kent, Canterbury, UK
2 shared publications
Latest Publications
- Open Access
- 23 July 2026
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 25 (1) , 2696617
Healthcare professionals’ perspectives and preferences regarding adolescent meningococcal disease vaccination in the United States
Invasive meningococcal disease (IMD) is a vaccine-preventable, serious disease. In 2023-2024, the United States (US) Advisory Committee on Immunization Practices (ACIP) proposed revisions to the adolescent meningococcal vaccine schedule. This survey aimed to understand healthcare professionals' (HCPs') perspectives on these revisions and the potential role of the meningococcal serogroups A, B, C, W, Y (MenABCWY) vaccine. An online survey was conducted in May - June 2025 among US HCPs who regularly recommend meningococcal vaccines for 16-23-year-old patients. Responses were analyzed descriptively. Of 302 HCPs, 73.2% felt the MenABCWY vaccine provides significant value to the meningococcal vaccination program, and almost half preferred a two-dose MenABCWY schedule over the ACIP recommendation, wherein a MenABCWY dose is followed by a MenB dose. Most HCPs indicated concern with removing MenACWY vaccination for 11-12-year-olds (84.8%). Comparatively, fewer were concerned about changing the MenB vaccine recommendation from shared clinical decision-making to risk-based (60.6%) and administering the second MenB dose closer to college entry (48.7%). While HCPs were receptive to revisions that simplify the vaccine schedule, this was not without concerns. The adolescent vaccination platform is essential to ensure continued protection against IMD; any changes will require clear, evidence-based guidance.
- 23 July 2026
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 25 (1) , 2696617
Open AccessHealthcare professionals’ perspectives and preferences regarding adolescent meningococcal disease vaccination in the United States
Invasive meningococcal disease (IMD) is a vaccine-preventable, serious disease. In 2023-2024, the United States (US) Advisory Committee on Immunization Practices (ACIP) proposed revisions to the adolescent meningococcal vaccine schedule. This survey aimed to understand healthcare professionals' (HCPs') perspectives on these revisions and the potential role of the meningococcal serogroups A, B, C, W, Y (MenABCWY) vaccine. An online survey was conducted in May - June 2025 among US HCPs who regularly recommend meningococcal vaccines for 16-23-year-old patients. Responses were analyzed descriptively. Of 302 HCPs, 73.2% felt the MenABCWY vaccine provides significant value to the meningococcal vaccination program, and almost half preferred a two-dose MenABCWY schedule over the ACIP recommendation, wherein a MenABCWY dose is followed by a MenB dose. Most HCPs indicated concern with removing MenACWY vaccination for 11-12-year-olds (84.8%). Comparatively, fewer were concerned about changing the MenB vaccine recommendation from shared clinical decision-making to risk-based (60.6%) and administering the second MenB dose closer to college entry (48.7%). While HCPs were receptive to revisions that simplify the vaccine schedule, this was not without concerns. The adolescent vaccination platform is essential to ensure continued protection against IMD; any changes will require clear, evidence-based guidance.
- Open Access
- 7 July 2025
- Published by SAGE Publications in Journal of Patient Experience
- Vol. 12
Preferences of Patients With cTTP and Other Chronic Conditions for At-Home Prophylactic Infusions: A Discrete Choice Experiment
Gaining an understanding of patient preferences regarding treatment administration can help inform approaches to patient care. A discrete choice experiment survey comprising of 7 attributes (treatment environment, convenience, travel times, waiting times, interactions with patients, interactions with healthcare providers, and concerns about complications) was used to assess the stated preferences of patients with chronic conditions, including congenital thrombotic thrombocytopenic purpura (cTTP), for receiving intravenous prophylactic infusions administered at home versus in an outpatient setting. The survey also contained a time trade-off exercise. In total, 307 survey responses were included in the analyses, of which 25 were from patients with cTTP. An overall preference for receiving infusions at home was reported by 137 patients (44.6%), and a high proportion of patients (n = 187, 60.9%) were willing to trade at least 12 months of their lives to receive treatment at home. Patients considered being comfortable with the treatment environment to be the most important attribute. These findings provide insights into the importance of the treatment setting preferences of patients with chronic conditions receiving prophylactic infusions.
- 7 July 2025
- Published by SAGE Publications in Journal of Patient Experience
- Vol. 12
Open AccessPreferences of Patients With cTTP and Other Chronic Conditions for At-Home Prophylactic Infusions: A Discrete Choice Experiment
Gaining an understanding of patient preferences regarding treatment administration can help inform approaches to patient care. A discrete choice experiment survey comprising of 7 attributes (treatment environment, convenience, travel times, waiting times, interactions with patients, interactions with healthcare providers, and concerns about complications) was used to assess the stated preferences of patients with chronic conditions, including congenital thrombotic thrombocytopenic purpura (cTTP), for receiving intravenous prophylactic infusions administered at home versus in an outpatient setting. The survey also contained a time trade-off exercise. In total, 307 survey responses were included in the analyses, of which 25 were from patients with cTTP. An overall preference for receiving infusions at home was reported by 137 patients (44.6%), and a high proportion of patients (n = 187, 60.9%) were willing to trade at least 12 months of their lives to receive treatment at home. Patients considered being comfortable with the treatment environment to be the most important attribute. These findings provide insights into the importance of the treatment setting preferences of patients with chronic conditions receiving prophylactic infusions.
- Open Access
- 1 July 2025
- Published by SAGE Publications in MDM Policy & Practice
- Vol. 10 (2)
Patient Preferences in Neoadjuvant Therapy for HER2+ Early-Stage Breast Cancer
Purpose. Health technology assessment (HTA) focuses on overall survival (OS) as the key clinical endpoint when making oncology treatment decisions. However, capturing robust OS estimates in early-stage breast cancer (eBC) is challenging, and patients may value other endpoints. This study assessed patient preferences for treatment attributes and endpoints in neoadjuvant therapy where mature and nonconfounded OS is rarely available. Patients and Methods. An online discrete choice experiment (DCE) was developed with health care professionals and patient advisory groups and conducted in Germany, France, Italy, and Spain with patients with HER2+ eBC. Patients were presented with 15 tasks and in each asked to choose between 2 hypothetical treatment options or to opt out in the neoadjuvant setting. Treatment attributes included OS at 5-years, disease-free survival (DFS) at 5-years, pathological complete response (pCR), impact of side effects on quality of life (QoL), and ability to receive breast-conserving surgery (BCS). Data were analyzed using multinomial logit and random parameters logit models. Results. Three hundred thirty-four patients with HER2+ eBC responded. The most valued attribute was achieving pCR (no invasive cancer in the breast and lymph nodes in all patients after treatment), followed by 5-y DFS in 95% of patients. OS ranked third in importance. The ability to undergo BCS and the impact of side effects on QoL were less important. Preferences varied by hormone receptor status, time since diagnosis, cancer stage, and age. Conclusion. Our findings are in-line with regulatory reviews, which accept pCR, DFS, and OS as clinically valid endpoints. When recommending reimbursements for treatments, HTA bodies and payers should consider patient preferences for treatment attributes and endpoints in their decision making when valuing new cancer treatments. Highlights: Traditional cancer treatment assessments focus on overall survival (OS), but in early-stage breast (eBC) cancer, patients may prioritize other treatment outcomes, since robust OS data may be unavailable. A discrete choice experiment was conducted with 334 patients with HER2+ eBC in the neoadjuvant setting in Germany, France, Italy, and Spain. Patients considered achieving pathological complete response (no invasive cancer in the breast and lymph nodes in all patients after treatment) to be the most important attribute when making a treatment decision, followed by disease free-survival (DFS) and OS; the ability to undergo breast-conserving surgery and the impact of side effects on quality of life were less important. These insights highlight the need for health authorities and reimbursement bodies to consider patient-valued outcomes beyond OS in eBC treatment evaluations.
- 1 July 2025
- Published by SAGE Publications in MDM Policy & Practice
- Vol. 10 (2)
Open AccessPatient Preferences in Neoadjuvant Therapy for HER2+ Early-Stage Breast Cancer
Purpose. Health technology assessment (HTA) focuses on overall survival (OS) as the key clinical endpoint when making oncology treatment decisions. However, capturing robust OS estimates in early-stage breast cancer (eBC) is challenging, and patients may value other endpoints. This study assessed patient preferences for treatment attributes and endpoints in neoadjuvant therapy where mature and nonconfounded OS is rarely available. Patients and Methods. An online discrete choice experiment (DCE) was developed with health care professionals and patient advisory groups and conducted in Germany, France, Italy, and Spain with patients with HER2+ eBC. Patients were presented with 15 tasks and in each asked to choose between 2 hypothetical treatment options or to opt out in the neoadjuvant setting. Treatment attributes included OS at 5-years, disease-free survival (DFS) at 5-years, pathological complete response (pCR), impact of side effects on quality of life (QoL), and ability to receive breast-conserving surgery (BCS). Data were analyzed using multinomial logit and random parameters logit models. Results. Three hundred thirty-four patients with HER2+ eBC responded. The most valued attribute was achieving pCR (no invasive cancer in the breast and lymph nodes in all patients after treatment), followed by 5-y DFS in 95% of patients. OS ranked third in importance. The ability to undergo BCS and the impact of side effects on QoL were less important. Preferences varied by hormone receptor status, time since diagnosis, cancer stage, and age. Conclusion. Our findings are in-line with regulatory reviews, which accept pCR, DFS, and OS as clinically valid endpoints. When recommending reimbursements for treatments, HTA bodies and payers should consider patient preferences for treatment attributes and endpoints in their decision making when valuing new cancer treatments. Highlights: Traditional cancer treatment assessments focus on overall survival (OS), but in early-stage breast (eBC) cancer, patients may prioritize other treatment outcomes, since robust OS data may be unavailable. A discrete choice experiment was conducted with 334 patients with HER2+ eBC in the neoadjuvant setting in Germany, France, Italy, and Spain. Patients considered achieving pathological complete response (no invasive cancer in the breast and lymph nodes in all patients after treatment) to be the most important attribute when making a treatment decision, followed by disease free-survival (DFS) and OS; the ability to undergo breast-conserving surgery and the impact of side effects on quality of life were less important. These insights highlight the need for health authorities and reimbursement bodies to consider patient-valued outcomes beyond OS in eBC treatment evaluations.
- 22 December 2023
- Published by Elsevier in Value in Health
- Vol. 26 (12) , S452-S453
PCR23 Patient Preferences for Treatment Attributes and Endpoints in Neoadjuvant Therapy for Early-Stage Breast Cancer
- 22 December 2023
- Published by Elsevier in Value in Health
- Vol. 26 (12) , S452-S453
PCR23 Patient Preferences for Treatment Attributes and Endpoints in Neoadjuvant Therapy for Early-Stage Breast Cancer
- Open Access
- 8 July 2022
- Published by Taylor & Francis in Future Oncology
- Vol. 18 (25) , 2843-2856
Physician treatment preferences for relapsed/refractory multiple myeloma: a discrete choice experiment
Aim: This study aimed to assess physician preferences for later lines (third to fifth) of therapy in patients with relapsed/refractory multiple myeloma (RRMM) in the USA. Materials & methods: Facto... Plain language summary When deciding which treatment patients with relapsed or refractory multiple myeloma should receive, physicians have to weigh the benefits of each treatment against the risk o... Graphical abstract
- 8 July 2022
- Published by Taylor & Francis in Future Oncology
- Vol. 18 (25) , 2843-2856
Open AccessPhysician treatment preferences for relapsed/refractory multiple myeloma: a discrete choice experiment
Aim: This study aimed to assess physician preferences for later lines (third to fifth) of therapy in patients with relapsed/refractory multiple myeloma (RRMM) in the USA. Materials & methods: Facto... Plain language summary When deciding which treatment patients with relapsed or refractory multiple myeloma should receive, physicians have to weigh the benefits of each treatment against the risk o... Graphical abstract
- Open Access
- 1 September 2021
- Published by Springer Nature in The European Journal of Health Economics
- Vol. 23 (3) , 357-374
Valuing informal carers’ quality of life using best-worst scaling—Finnish preference weights for the Adult Social Care Outcomes Toolkit for carers (ASCOT-Carer)
This study developed Finnish preference weights for the seven-attribute Adult Social Care Outcomes Toolkit for carers (ASCOT-Carer) and investigated survey fatigue and learning in best-worst scaling (BWS) experiments. An online survey that included a BWS experiment using the ASCOT-Carer was completed by a sample from the general population in Finland. A block of eight BWS profiles describing different states from the ASCOT-Carer were randomly assigned to each respondent, who consecutively made four choices (best, worst, second best and second worst) per profile. The analysis panel data had 32,160 choices made by 1005 respondents. A scale multinomial logit (S-MNL) model was used to estimate preference weights for 28 ASCOT-Carer attribute levels. Fatigue and learning effects were examined as scale heterogeneity. Several specifications of the generalised MNL model were employed to ensure the stability of the preference estimates. The most and least-valued states were the top and bottom levels of the control over daily life attribute. The preference weights were not on a cardinal scale. We observed the position effect of the attributes on preferences associated with the best or second-best choices. A learning effect was found. The established preference weights can be used in evaluations of the effects of long-term care services and interventions on the quality of life of service users and caregivers. The learning effect implies a need to develop study designs that ensure equal consideration to all profiles (choice tasks) in a sequential choice experiment.
- 1 September 2021
- Published by Springer Nature in The European Journal of Health Economics
- Vol. 23 (3) , 357-374
Open AccessValuing informal carers’ quality of life using best-worst scaling—Finnish preference weights for the Adult Social Care Outcomes Toolkit for carers (ASCOT-Carer)
This study developed Finnish preference weights for the seven-attribute Adult Social Care Outcomes Toolkit for carers (ASCOT-Carer) and investigated survey fatigue and learning in best-worst scaling (BWS) experiments. An online survey that included a BWS experiment using the ASCOT-Carer was completed by a sample from the general population in Finland. A block of eight BWS profiles describing different states from the ASCOT-Carer were randomly assigned to each respondent, who consecutively made four choices (best, worst, second best and second worst) per profile. The analysis panel data had 32,160 choices made by 1005 respondents. A scale multinomial logit (S-MNL) model was used to estimate preference weights for 28 ASCOT-Carer attribute levels. Fatigue and learning effects were examined as scale heterogeneity. Several specifications of the generalised MNL model were employed to ensure the stability of the preference estimates. The most and least-valued states were the top and bottom levels of the control over daily life attribute. The preference weights were not on a cardinal scale. We observed the position effect of the attributes on preferences associated with the best or second-best choices. A learning effect was found. The established preference weights can be used in evaluations of the effects of long-term care services and interventions on the quality of life of service users and caregivers. The learning effect implies a need to develop study designs that ensure equal consideration to all profiles (choice tasks) in a sequential choice experiment.
- Open Access
- 30 November 2020
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 18 (1) , 1-12
Rasch analysis of the long-term conditions questionnaire (LTCQ) and development of a short-form (LTCQ-8)
Background: The aim of the current study was to evaluate the structural validity of the 20-item long-term conditions questionnaire (LTCQ) and to explore a potential short-form version of the scale using Rasch analysis. Methods: Data were collected through postal surveys (February 2016–January 2017) from a sample of 1,211 participants diagnosed with at least one long-term condition (LTC). Identified participants were invited through either local authorities for a social care cohort (n = 294) or primary care practices for a health care cohort (n = 917). Participants were mailed a survey, including the LTCQ, demographic questions, a comorbidities measure, and other validated outcome measures. Respondents were invited to complete a follow-up survey including the LTCQ for assessment of reproducibility. Results: The main assumptions of the Rasch model from the LTCQ were fulfilled, although infit and outfit indices indicated some items showed misfit. Misfitted items, items that did not have a preceding set or showed some local dependence were removed one at a time, with the remaining candidate items to form an 8-item short version, the LTCQ-8. The Rasch model for the LTCQ-8 explained 64% variance and had a reliability estimate greater than 0.80. Several items in the LTCQ showed uniform differential item function (DIF) in relation to the number of reported LTCs, age, cohort and type of LTCs, but fewer items exhibited DIF in the LTCQ-8. Spearman’s rho correlations between the LTCQ and the LTCQ-8 were strong across the total sample and various subgroups. Correlations between the LTCQ-8 and all reference measures were moderate to strong, and comparable to correlations found between the LTCQ and these measures. Conclusions: The LTCQ measures a unidimensional construct, and it is therefore acceptable to use a summed total score. The LTCQ-8 also met the assumption of unidimensionality and had comparable construct validity with the LTCQ. Additional validation is required in an independent sample.
- 30 November 2020
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 18 (1) , 1-12
Open AccessRasch analysis of the long-term conditions questionnaire (LTCQ) and development of a short-form (LTCQ-8)
Background: The aim of the current study was to evaluate the structural validity of the 20-item long-term conditions questionnaire (LTCQ) and to explore a potential short-form version of the scale using Rasch analysis. Methods: Data were collected through postal surveys (February 2016–January 2017) from a sample of 1,211 participants diagnosed with at least one long-term condition (LTC). Identified participants were invited through either local authorities for a social care cohort (n = 294) or primary care practices for a health care cohort (n = 917). Participants were mailed a survey, including the LTCQ, demographic questions, a comorbidities measure, and other validated outcome measures. Respondents were invited to complete a follow-up survey including the LTCQ for assessment of reproducibility. Results: The main assumptions of the Rasch model from the LTCQ were fulfilled, although infit and outfit indices indicated some items showed misfit. Misfitted items, items that did not have a preceding set or showed some local dependence were removed one at a time, with the remaining candidate items to form an 8-item short version, the LTCQ-8. The Rasch model for the LTCQ-8 explained 64% variance and had a reliability estimate greater than 0.80. Several items in the LTCQ showed uniform differential item function (DIF) in relation to the number of reported LTCs, age, cohort and type of LTCs, but fewer items exhibited DIF in the LTCQ-8. Spearman’s rho correlations between the LTCQ and the LTCQ-8 were strong across the total sample and various subgroups. Correlations between the LTCQ-8 and all reference measures were moderate to strong, and comparable to correlations found between the LTCQ and these measures. Conclusions: The LTCQ measures a unidimensional construct, and it is therefore acceptable to use a summed total score. The LTCQ-8 also met the assumption of unidimensionality and had comparable construct validity with the LTCQ. Additional validation is required in an independent sample.
- Open Access
- 1 April 2020
- Published by Elsevier in Social Science & Medicine
- Vol. 250, 112792
Population-based preference weights for the Adult Social Care Outcomes Toolkit (ASCOT) for service users for Austria: Findings from a best-worst experiment
- 1 April 2020
- Published by Elsevier in Social Science & Medicine
- Vol. 250, 112792
Open AccessPopulation-based preference weights for the Adult Social Care Outcomes Toolkit (ASCOT) for service users for Austria: Findings from a best-worst experiment
- Open Access
- 1 December 2019
- Published by Elsevier in Value in Health
- Vol. 22 (12) , 1427-1440
Carer Social Care-Related Quality of Life Outcomes: Estimating English Preference Weights for the Adult Social Care Outcomes Toolkit for Carers
- 1 December 2019
- Published by Elsevier in Value in Health
- Vol. 22 (12) , 1427-1440
Open AccessCarer Social Care-Related Quality of Life Outcomes: Estimating English Preference Weights for the Adult Social Care Outcomes Toolkit for Carers
- Open Access
- 3 April 2019
- Published by Springer Nature in Quality of Life Research
- Vol. 28 (8) , 2207-2220
Comparing internet and face-to-face surveys as methods for eliciting preferences for social care-related quality of life: evidence from England using the ASCOT service user measure
Purpose Traditionally, researchers have relied on eliciting preferences through face-to-face interviews. Recently, there has been a shift towards using internet-based methods. Different methods of data collection may be a source of variation in the results. In this study, we compare the preferences for the Adult Social Care Outcomes Toolkit (ASCOT) service user measure elicited using best–worst scaling (BWS) via a face-to-face interview and an online survey. Methods Data were collected from a representative sample of the general population in England. The respondents (face-to-face: n = 500; online: n = 1001) completed a survey, which included the BWS experiment involving the ASCOT measure. Each respondent received eight best–worst scenarios and made four choices (best, second best, worst, second worst) in each scenario. Multinomial logit regressions were undertaken to analyse the data taking into account differences in the characteristics of the two samples and the repeated nature of the data. Results We initially found a number of small significant differences in preferences between the two methods across all ASCOT domains. These differences were substantially reduced—from 15 to 5 out of 30 coefficients being different at the 5% level—and remained small in value after controlling for differences in observable and unobservable characteristics of the two samples. Conclusions This comparison demonstrates that face-to-face and internet surveys may lead to fairly similar preferences for social care-related quality of life when differences in sample characteristics are controlled for. With or without a constant sampling frame, studies should carefully design the BWS exercise and provide similar levels of clarification to participants in each survey to minimise the amount of error variance in the choice process.
- 3 April 2019
- Published by Springer Nature in Quality of Life Research
- Vol. 28 (8) , 2207-2220
Open AccessComparing internet and face-to-face surveys as methods for eliciting preferences for social care-related quality of life: evidence from England using the ASCOT service user measure
Purpose Traditionally, researchers have relied on eliciting preferences through face-to-face interviews. Recently, there has been a shift towards using internet-based methods. Different methods of data collection may be a source of variation in the results. In this study, we compare the preferences for the Adult Social Care Outcomes Toolkit (ASCOT) service user measure elicited using best–worst scaling (BWS) via a face-to-face interview and an online survey. Methods Data were collected from a representative sample of the general population in England. The respondents (face-to-face: n = 500; online: n = 1001) completed a survey, which included the BWS experiment involving the ASCOT measure. Each respondent received eight best–worst scenarios and made four choices (best, second best, worst, second worst) in each scenario. Multinomial logit regressions were undertaken to analyse the data taking into account differences in the characteristics of the two samples and the repeated nature of the data. Results We initially found a number of small significant differences in preferences between the two methods across all ASCOT domains. These differences were substantially reduced—from 15 to 5 out of 30 coefficients being different at the 5% level—and remained small in value after controlling for differences in observable and unobservable characteristics of the two samples. Conclusions This comparison demonstrates that face-to-face and internet surveys may lead to fairly similar preferences for social care-related quality of life when differences in sample characteristics are controlled for. With or without a constant sampling frame, studies should carefully design the BWS exercise and provide similar levels of clarification to participants in each survey to minimise the amount of error variance in the choice process.